Cover Image
市場調查報告書

經皮、粘膜藥物遞輸市場

Transdermal and Transmucosal Drug Delivery Markets

出版商 Kalorama Information 商品編碼 347848
出版日期 內容資訊 英文 128 Pages
訂單完成後即時交付
價格
Back to Top
經皮、粘膜藥物遞輸市場 Transdermal and Transmucosal Drug Delivery Markets
出版日期: 2015年11月25日 內容資訊: 英文 128 Pages
簡介

經皮/粘膜藥物遞輸,是對治療有效的藥物廣受確立的給藥途徑。經皮/粘膜藥物遞輸,在首發醫藥品、非專利處方藥雙方的廣泛治療的開發中持續發揮重要作用。

本報告提供全球經皮、粘膜藥物遞輸市場現況與展望調查分析、經皮藥物遞輸的優點及缺點、經皮藥物遞輸的各種種類與概要、主要市場趨勢與新的開發趨勢、經皮/粘膜藥物遞輸市場變化與預測 (各地區、治療領域、藥物/藥物輸送零件) 、競爭環境,及主要企業的簡介等彙整。

第1章 摘要整理

第2章 簡介、概要

  • 調查範圍、調查手法
  • 經皮/粘膜藥物遞輸系統的理由
  • 藥物作用的階段
  • 經皮藥物遞輸
  • 經皮藥物遞輸的歷史
  • 經皮藥物遞輸的優點
  • 經皮藥物遞輸的缺點
  • 被動的經皮藥物遞輸
  • Transfersomes ®
  • 藥物的tattoo
  • Crystal Reservoir技術
  • 積極的經皮藥物遞輸
  • 經皮微針頭藥物遞輸
  • 電傳導藥物遞輸
  • 離子電滲
  • 超音波導入
  • 磁游泳動
  • Photomechanical Waves
  • 粘膜藥物遞輸
  • 口腔藥物遞輸
  • 陰道粘膜藥物遞輸

第3章 趨勢、發展

  • 新的經皮的認證
  • 經皮藥物遞輸的革新
  • 黏合技術與課題
  • 黏合市場課題
  • 非專利經皮產品的研究設計指南
  • 生物技術問題
  • 胰島素給藥的發展
  • 荷爾蒙藥物遞輸的新發展
  • 新的粘膜/口腔藥物遞輸系統
  • 其他的新藥物遞輸系統
  • 微針頭的經皮藥物遞輸
  • 調整熱能技術
  • 新的超音波技術
  • 開發中的經皮產品

第4章 市場規模、成長

  • 經皮/粘膜藥物遞輸市場整體
  • 經皮子區分市場
  • 經皮/粘膜市場:各應用領域
  • 市場分析:各地區
  • 僅經皮/粘膜藥物遞輸技術市場

第5章 競爭分析

  • 競爭環境
  • 新興參與企業
  • 市場分析

第6章 企業簡介

  • 3M Pharmaceuticals
  • Acrux Limited
  • ALZA Corporation
  • Antares Pharma, Inc.
  • Apricus BioSciences, Inc
  • Aveva Drug Delivery Systems
  • Corium International, Inc
  • DURECT Corporation
  • Generex Biotechnology Corporation
  • Inovio Pharmaceuticals, Inc.
  • Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
  • MedPharm LTD
  • Mylan, Inc.
  • Nemaura Pharma Ltd
  • 日東電工
  • Noven Pharmaceuticals, Inc.
  • Pantec Biosolutions AG
  • Tapemark
  • tesa Labtec GmbH
  • TEVA Pharmaceutical Industries Ltd.
  • Zosano Pharma

附錄:企業名錄

圖表

目錄
Product Code: KLI5774708

Transdermal/transmucosal drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. Transdermal/transmucosal drug delivery continues to play an important role in the development of a variety of therapeutic areas in both brand and generic products.

Transdermal and Transmucosal Drug Delivery Markets analyzes the current and potential markets for transdermal/transmucosal drug delivery.

New applications continue to emerge for transdermal/transmucosal drug delivery including migraine, HIV, osteoporosis, stroke and restless leg syndrome treatments. There is no potential limit for the therapeutic area for development of transdermal systems. In transdermal drug delivery, a great challenge is to provide products that deliver biologics, including vaccines, peptides and proteins, without the use of injection.

The potential benefits that may be achieved using transdermal delivery include continuous, controlled release and absorption of medication into the body; avoiding presystemic metabolism that may occur following oral dosing, including both intestinal and hepatic first-pass metabolism; improving patient compliance by offering more convenient dosing regimens, such as once or twice weekly dosing; and the ability to quickly discontinue treatment by removal of the system.

Transdermal and Transmucosal Drug Delivery Markets provides the following market information:

  • The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and Pharmaceuticals, 2013-2020
  • The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug Delivery Systems by Type, 2013-2020
  • The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug Delivery Technologies, Market Share by Type, 2013-2020
  • Transdermal/Transmucosal Drug Delivery by Indication by Percent, 2015 (Smoking Cessation, Pain Management, Hormone, Cardio, Others)
  • The Transdermal/Transmucosal Drug Delivery Market by Region, 2013-2020 (United States, Europe, Japan, Rest of World, Global Market)
  • The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2013-2020
  • Leading Suppliers of Transdermal/Transmucosal Drug Delivery Technology

To date, there are numerous transdermal products that have gained significant commercial success and provided unique benefits for patients. In addition to those mentioned previously, smoking cessation, hypertension, pain management and motion sickness are other areas with important transdermal products available.

The transdermal/transmucosal drug delivery market consists of many companies including large and small pharmaceutical companies as well as large and small drug delivery companies. The competition among participants is intensifying not only within the specific category such as transdermal drug delivery but also among the competing drug delivery technologies to provide the best possible vehicle for administration of a particular pharmaceutical product.

Drug delivery companies have made tremendous strides in the transdermal/transmucosal drug delivery market. Several companies have products that are already enjoying market success while many others are at various stages of development. There is little doubt that this area of drug delivery will continue to flourish in the coming years.

The report profiles companies involved in the transdermal/transmucosal drug delivery market, including:

  • 3M Pharmaceuticals
  • Acrux Limited
  • ALZA Corporation
  • Antares Pharma, Inc.
  • Apricus BioSciences, Inc.
  • Aveva Drug Delivery Systems
  • Corium International, Inc.
  • DURECT Corporation
  • Generex Biotechnology Corporation
  • Inovio Pharmaceuticals, Inc.
  • Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
  • MedPharm LTD
  • Mylan, Inc.
  • Nemaura Pharma Ltd
  • Nitto Denko Corporation
  • Noven Pharmaceuticals, Inc.
  • Pantec Biosolutions AG
  • Tapemark
  • tesa Labtec GmbH
  • TEVA Pharmaceutical Industries Ltd.
  • Zosano Pharma

Continued research is necessary to fully appreciate the benefits of transdermal treatments. Certainly challenges remain for the development of transdermal/transmucosal drug delivery systems but continued research will likely break down the barriers that limit the types of drug molecules that may be delivered through the skin, with increased molecular size and complexity presenting the biggest obstacles.

The market is expected to be driven by various factors including the loss of patent protection for blockbuster drugs and the need to avoid the first pass effects of oral drug delivery. Additionally, with an added focus on active transdermal technologies, new applications will likely cause a resurgence of interest in transdermal delivery of products.

Table of Contents

ONE: EXECUTIVE SUMMARY

  • Market Drivers
  • Market Size and Growth
  • Total Transdermal/Transmucosal Drug Delivery Market
  • Transdermal/Transmucosal Drug Delivery Only Market
  • Competitive and Market Analysis

TWO: INTRODUCTION AND OVERVIEW

  • Scope and Methodology
  • Reasons for Transdermal/Transmucosal Drug Delivery Systems
  • Phases of Drug Action
  • Transdermal Drug Delivery
  • History of Transdermal Drug Delivery
  • Advantages of Transdermal Drug Delivery
  • Disadvantages of Transdermal Drug Delivery
  • Passive Transdermal Drug Delivery
  • Transfersomes
  • Medicated Tattoos
  • Crystal Reservoir Technology
  • Active Transdermal Drug Delivery
  • Transdermal Microneedle Drug Delivery
  • Electrotransport Drug Delivery
  • Iontophoresis
  • Sonophoresis
  • Magnetophoresis
  • Photomechanical Waves
  • Transmucosal Drug Delivery
  • Buccal Drug Delivery
  • Vaginal Drug Delivery

THREE: TRENDS AND DEVELOPMENTS

  • Novel Transdermal Approvals
  • Innovations in Transdermal Drug Delivery
  • Adhesive Technology and Issues
  • Adhesive Market Issues
  • Generic Transdermal Study Design Guidelines
  • Biotechnological Issues
  • Developments in Insulin Delivery
  • New Developments in Hormone Drug Delivery
  • New Mucosal/Buccal Delivery Systems
  • Other Drug Delivery Systems
  • Microneedle-Assisted Transdermal Drug Delivery
  • Controlled Thermal Energy Technology
  • New Ultrasound Technology
  • Transdermal Products in Development

FOUR: MARKET SIZE AND GROWTH

  • The Total Transdermal/Transmucosal Drug Delivery Market
  • Transdermal Subsegment Market
  • Transdermal/Transmucosal Market by Application

MARKET ANALYSIS BY REGION

  • Transdermal/Transmucosal Delivery Technology Only Market

FIVE: COMPETITIVE ANALYSIS

  • Competitive Landscape
  • Emerging Participants
  • Market Analysis

SIX: COMPANY PROFILES

  • 3M Pharmaceuticals
  • Acrux Limited
  • ALZA Corporation
  • Antares Pharma, Inc.
  • Apricus BioSciences, Inc
  • Aveva Drug Delivery Systems
  • Corium International, Inc
  • DURECT Corporation
  • Generex Biotechnology Corporation
  • Inovio Pharmaceuticals, Inc.
  • Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
  • MedPharm LTD
  • Mylan, Inc.
  • Nemaura Pharma Ltd
  • Nitto Denko Corporation
  • Noven Pharmaceuticals, Inc.
  • Pantec Biosolutions AG
  • Tapemark
  • tesa Labtec GmbH
  • TEVA Pharmaceutical Industries Ltd.
  • Zosano Pharma

APPENDIX: COMPANY DIRECTORY

TABLE OF EXHIBITS

TWO: INTRODUCTION AND OVERVIEW

  • Table 2-1: Sequence of Drug Action
  • Table 2-2: Select Leading Transdermal Delivery-Based Products

THREE: TRENDS AND DEVELOPMENTS

  • Table 3-1: Selected Transdermal Products in Development

FOUR: MARKET SIZE AND GROWTH

  • Table 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and Pharmaceuticals, 2013-2020
  • Figure 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and Pharmaceuticals, 2013-2020
  • Table 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug Delivery Systems by Type, 2013-2020
  • Figure 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug Delivery Systems, Revenues by Type, 2013-2020
  • Table 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug Delivery Technologies, Market Share by Type, 2013-2020
  • Figure 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug Delivery Technologies by Type, 2015
  • Figure 4-4: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug Delivery Technologies by Type, 2020
  • Table 4-4: The Worldwide Market for Transdermal Drug Delivery Systems by Type, 2013-2020
  • Figure 4-6: The Worldwide Market for Pharmaceuticals Utilizing Transdermal Drug Delivery Systems, Revenues by Type, 2013-2020 (Passive, Active)
  • Figure 4-7: Transdermal/Transmucosal Drug Delivery by Indication by Percent, 2015(Smoking Cessation, Pain Management, Hormone, Cardio, Others)
  • Table 4-5: The Transdermal/Transmucosal Drug Delivery Market by Region, 2013-2020(United States, Europe, Japan, Rest of World, Global Market)
  • Figure 4-8: The Worldwide Transdermal/Transmucosal Drug Delivery Market by Region,2013-2020 (United States, Europe, Japan, Rest of World)
  • Figure 4-9: The Worldwide Transdermal/Transmucosal Drug Delivery Market, Distribution of Sales by Region, 2015 (United States, Europe, Japan, Rest of World)
  • Table 4-6: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems by Pharmaceutical and Drug Delivery Component, 2013-2020
  • Table 4-7: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component,2013-2020
  • Figure 4-10: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component,2013-2020 (Drug Delivery Technology Revenues; Pharmaceutical Revenues,Utilizing Drug Delivery Technology)
  • Figure 4-11: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2015(Drug Delivery Technology Revenues; Pharmaceutical Revenues, Utilizing Drug Delivery Technology)
  • Figure 4-12: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2020(Drug Delivery Technology Revenues; Pharmaceutical Revenues, Utilizing Drug Delivery Technology)

FIVE: COMPETITIVE ANALYSIS

  • Table 5-1: Leading Suppliers of Transdermal/Transmucosal Drug Delivery Technology
Back to Top